COVID-19 vaccination by hospitals deemed composite supply with vaccine sale as principal component taxable at 5%

The AAAR held that COVID-19 vaccination by hospitals constitutes a composite supply where the principal supply is sale of vaccine (goods) and auxiliary supply is administration service. The transaction is predominantly sale of goods, not healthcare services, as recipients consciously choose and pay for the vaccine with transfer of medicine occurring. Vaccination does not qualify as healthcare services under GST exemption since it's administered before disease onset, unlike diagnosis/treatment/care for existing illness. The supply is taxable at 5% rate applicable to the principal supply component. The appellant's claim for exemption was rejected.

---

---

Issues Involved:
1. Classification of administering COVID-19 vaccination by hospitals as a supply of goods or services.
2. Qualification of administering COVID-19 vaccination by clinical establishments as "Health care services" under Notification No. 12/2017 Central Tax Rate.
3. Eligibility of exemption under GST for administering COVID-19 vaccination by clinical establishments.

Detailed Analysis:

1. Classification of Administering COVID-19 Vaccination by Hospitals as a Supply of Goods or Services:

The appellant argued that the process of vaccination should be considered a supply of service rather than a sale of goods. They contended that the hospital is not selling the vaccine to the recipient, as there is no transfer of title of the vaccine to the recipient. The appellant emphasized that the essence of the supply is the service of administering the vaccine, fulfilling the recipient's desire to get immunized.

However, the authority concluded that the transaction is a composite supply, with the principal supply being the receipt of the vaccine (supply of goods) and the administration of the vaccine (supply of service) as auxiliary. The authority noted that the recipient's primary intention is to receive the vaccine, which is then administered. The vaccine vial contains multiple doses, and one dose is injected into the recipient, indicating a transfer of goods. The authority also referenced government guidelines and pricing structures, which include a tax component on the vaccine (goods) and a service charge for administration, reinforcing the classification as a composite supply taxable at 5%.

2. Qualification of Administering COVID-19 Vaccination by Clinical Establishments as "Health Care Services":

The appellant argued that administering the COVID-19 vaccine should qualify as "Health care services" under Notification No. 12/2017 Central Tax Rate, which exempts healthcare services provided by clinical establishments, authorized medical practitioners, or paramedics.

The authority examined the definition of "Health care services" under the notification, which includes services for diagnosis, treatment, or care for illness, injury, deformity, abnormality, or pregnancy. They concluded that vaccination, which is administered to produce protection against disease before its onset, does not fit within this definition. The authority emphasized that healthcare services typically involve diagnosis or treatment after the advent of disease, whereas vaccination is a preventive measure.

3. Eligibility of Exemption under GST for Administering COVID-19 Vaccination by Clinical Establishments:

The appellant contended that the vaccination process should be exempt from GST as it qualifies as an outpatient healthcare service. They argued that the authority's interpretation was limited to inpatient services and did not consider outpatient services, which are also exempt under GST.

The authority, however, maintained that the exemption under Notification No. 12/2017 Central Tax Rate does not apply to the administration of COVID-19 vaccines. They reiterated that the transaction is a composite supply with the principal supply being the vaccine (goods) and the auxiliary supply being the administration service. The authority confirmed that the entire transaction is taxable at the rate applicable to the principal supply, i.e., 5%.

Conclusion:

The authority upheld the ruling of the Advance Ruling Authority, confirming that administering COVID-19 vaccination by hospitals is a composite supply, with the principal supply being the sale of the vaccine and the auxiliary supply being the service of administering the vaccine. The total transaction is taxable at the rate of the principal supply, which is 5%. The authority also concluded that administering COVID-19 vaccines does not qualify as "Health care services" under the relevant GST notification and is not eligible for exemption.

---